Company intelligence / Profile preview

Yidina

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Yidina (Shanghai) Biotechnology is a life science company specializing in the development and production of high-quality biological reagents, including recombinant proteins, antibodies, and ELISA kits. The company provides comprehensive CRO services to support drug discovery and development for pharmaceutical and biotechnology companies. Yidina's product portfolio covers various research areas such as oncology, immunology, and infectious diseases. They focus on providing reliable tools and services to accelerate life science research and clinical diagnostics.

Therapeutic areas: ImmunologyInfectious DiseasesOncology
Modalities: AntibodyRecombinant proteinBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Yidina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yidina.

Explore the full profile